{
    "Trade/Device Name(s)": [
        "Dimension Vista\u00ae CEA Flex\u00ae reagent cartridge",
        "Dimension Vista\u00ae LOCI 5 Calibrator"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics",
    "510(k) Number": "K071603",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031270"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHX",
        "JIX"
    ],
    "Summary Letter Date": "June 25, 2008",
    "Summary Letter Received Date": "June 3, 2008",
    "Submission Date": "June 2, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.6010"
    ],
    "Regulation Name(s)": [
        "Tumor-associated antigen immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Carcinoembryonic antigen (CEA)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista\u00ae System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "LOCI\u2122 technology"
    ],
    "Methodologies": [
        "Homogeneous sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista CEA Flex reagent cartridge and LOCI 5 Calibrator for quantitative measurement and calibration of carcinoembryonic antigen on the Dimension Vista System",
    "Indications for Use Summary": "Quantitative measurement of carcinoembryonic antigen in human serum and sodium or lithium heparin plasma as an aid in cancer patient management; LOCI 5 Calibrator for calibration of the CEA method on Dimension Vista System",
    "fda_folder": "Immunology"
}